Drug Pricing Bill: Senate Sponsors ‘Not Backing Down’ From Inflation Rebates
Executive Summary
Price inflation rebates are the linchpin of the legislation’s Democratic support, Sen. Chuck Grassley, R-IA, argues. But to many Republicans, they sound too much like price controls.
You may also be interested in...
Medicare Price Inflation Penalties Unlikely To Spur Greater Price Increases, Study Suggests
Results of an analysis published in JAMA could undercut arguments against legislative proposals establishing inflation penalties in Medicare.
White House Wants To Avoid Fight On Rebates, Get Quick Passage Of Senate Rx Pricing Bill
“We’re out of time for ideas," Domestic Policy Council Director Joe Grogan says. Trump administration is pushing hard to get the Senate drug pricing bill through Congress quickly and score a major victory for the President.
US Drug Importation: Hard To See Path Forward, Former HHS Adviser Says
Former drug pricing advisor John O’Brien discusses next steps for Administration policies around importation and international reference pricing during a speech to the Academy of Managed Care Pharmacy.